Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$84.76

2.79 (3.40%)

, KMB

Kimberly-Clark

$127.96

-2.28 (-1.75%)

10:30
04/23/19
04/23
10:30
04/23/19
10:30

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. 2. Kimberly-Clark (KMB) upgraded to Buy from Hold at Argus and to Outperform from Neutral at Macquarie. 3. Sanderson Farms (SAFM) upgraded to Neutral from Sell at Goldman Sachs with analyst Adam Samuelson saying African swine fever is upending the protein markets, Samuelson tells investors in a research note. 4. Visteon (VC) upgraded to Outperform from Neutral at Baird while Veoneer (VNE) was upgraded to Neutral from Underperform. 5. Sony (SNE) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

QCOM

Qualcomm

$84.76

2.79 (3.40%)

KMB

Kimberly-Clark

$127.96

-2.28 (-1.75%)

SAFM

Sanderson Farms

$143.73

2.16 (1.53%)

VC

Visteon

$80.45

-0.37 (-0.46%)

VNE

Veoneer

$28.16

-1.04 (-3.56%)

SNE

Sony

$47.95

0.34 (0.71%)

  • 25

    Apr

  • 26

    Apr

  • 01

    May

  • 02

    May

  • 06

    May

  • 08

    May

  • 23

    May

  • 29

    May

  • 30

    May

  • 23

    Jul

  • 13

    Nov

QCOM Qualcomm
$84.76

2.79 (3.40%)

04/23/19
MSCO
04/23/19
UPGRADE
MSCO
Overweight
Qualcomm upgraded to Overweight from Equal Weight at Morgan Stanley
04/23/19
MSCO
04/23/19
UPGRADE
Target $95
MSCO
Overweight
Morgan Stanley upgrades Qualcomm, thinks Apple pact not yet fully appreciated
As previously reported, Morgan Stanley analyst James Faucette upgraded Qualcomm (QCOM) to Overweight from Equal Weight, citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. Faucette thinks the settlement reinforces two key Qualcomm tenets - the best modem performance matters and that the best intellectual property has value. While he takes a more conservative view than most on the pace of 5G ramp, Faucette said he views Qualcomm as "the key enabler" of 5G technology. He raised his price target on Qualcomm shares to $95 from $55.
04/18/19
04/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PepsiCo (PEP) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong citing its "strong" Q1 results that saw organic revenue accelerate to 5% and gross margins top expectations. 2. J.M. Smucker (SJM) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Pamela Kaufman saying she believes the company's reinvestment strategy will drive improved topline momentum across its key segments and should allow the company to return to positive organic growth in FY20. 3. Venator Materials (VNTR) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying he believes that the titanium dioxide "cycle is turning", with destocking activity nearing completion amid improving global demand and pricing. 4. Ecolab (ECL) upgraded to Buy from Neutral at Nomura Instinet with analyst Dan Dolev saying with the problematic energy business soon to be spun-off, Ecolab's "recession resistant qualities should stand out, warranting a significant premium to peers." 5. Qualcomm (QCOM) upgraded to Buy from Hold at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
ARGS
04/18/19
NO CHANGE
Target $225
ARGS
Buy
Apple to benefit from Qualcomm litigation settlement, says Argus
Argus analyst Jim Kelleher kept his Buy rating and $225 price target on Apple (AAPL), saying the company's "comprehensive legal settlement and new supply agreement with Qualcomm (QCOM)" should benefit the shares. The analyst notes that the decision to settle was driven by the realization that Apple may miss out on the 5G phone cycle upgrade, and the announcement by Intel (INTC) within hours of the settlement highlighted that the Street was more optimistic about its development of a viable 5G chip. Kelleher adds that the cost burden for Qualcomm chip and licensing is not "too severe", which he estimates to be below $25 on devices that may retail for over $1.1K. The analyst also notes that Apple stock remains "attractive compared to its historical valuations and to peer average multiples."
KMB Kimberly-Clark
$127.96

-2.28 (-1.75%)

02/11/19
EXAN
02/11/19
INITIATION
Target $130
EXAN
Outperform
Kimberly-Clark initiated with an Outperform at Exane BNP Paribas
Exane BNP Paribas analyst Jeff Stent initiated Kimberly-Clark with an Outperform rating and $130 price target, stating that while the company faces structural challenges "if ever there is a time to buy, it is now" as the input cost picture improves and industry pricing is "starting to kick in."
02/11/19
EXAN
02/11/19
UPGRADE
Target $67
EXAN
Neutral
Exane upgrades Colgate-Palmolive to Neutral, names Kimberly-Clark top pick
Exane BNP Paribas analyst Jeff Stent upgraded Colgate-Palmolive (CL) to Neutral from Underperform and raised his price target for the shares to $67 from $56. Investor interest in Colgate will continue to build with its organic sales growth trends set to improve and with a management change "seemingly close," Stent tells investors in a research note. The analyst also raised his price target for Procter & Gamble (PG) to $95 from $86 and keeps an Underperform rating on the name. The company's near-term organic growth has an "upside bias," but this is already reflect in the stock following the "recent meteoric re-rating," Stent contends. In taking his Home and Personal Care coverage to three stocks, the analyst today also initiated coverage of Kimberly-Clark (KMB) with an Outperform rating and $130 price target. Kimberly-Clark is Stent's preferred way to play the U.S. Home and Personal Care space. While the company faces structural challenges, "if ever there is a time to buy, it is now" as the input cost picture improves and industry pricing is "starting to kick in," he says.
04/23/19
ARGS
04/23/19
UPGRADE
ARGS
Buy
Kimberly-Clark upgraded to Buy from Hold at Argus
04/23/19
MACQ
04/23/19
UPGRADE
MACQ
Outperform
Kimberly-Clark upgraded to Outperform from Neutral at Macquarie
SAFM Sanderson Farms
$143.73

2.16 (1.53%)

03/13/19
JPMS
03/13/19
UPGRADE
Target $127
JPMS
Underweight
JPMorgan upgrades Sanderson Farms to Neutral on balanced risk/reward
JPMorgan analyst Ken Goldman upgraded Sanderson Farms to Neutral from Underweight and raised his price target for the shares to $127 from $88. The analyst now views the stock's upside/downside risk as balanced. On the constructive side, industry bird weights are down, China "indeed could open," and Sanderson can post upside to consensus estimates, Goldman tells investors in a research note. However, on the less constructive side, the U.S. broiler industry is still planning on accelerating its capacity growth over the next couple of years, he adds.
04/23/19
GSCO
04/23/19
UPGRADE
Target $131
GSCO
Neutral
Sanderson Farms upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Adam Samuelson upgraded Sanderson Farms to Neutral from Sell and raised his price target for the shares to $131 from $81. African swine fever is upending the protein markets, Samuelson tells investors in a research note.
04/23/19
GSCO
04/23/19
DOWNGRADE
GSCO
Sell
Goldman downgrades Hormel to Sell, upgrades Sanderson to Neutral
Goldman Sachs analyst Adam Samuelson downgraded Hormel Foods (HRL) to Sell from Neutral and cut his price target for the shares to $35 from $37. With his estimates now below consensus and "limited" earnings growth forecasted through fiscal 2020, the analyst sees risk to Hormel's "premium" valuation. The breadth and depth of African swine fever's impact across the Chinese pork industry, and as a result the global protein industry, will be significant in the near-to-medium-term, Samuelson tells investors in a research note. Buy-rated Tyson Foods (TSN) and BRF S.A. (BRFS) remain the analyst's preferred way to gain exposure to the Global Protein market. Samuelson this morning also upgraded Sanderson Farms (SAFM) to Neutral from Sell and raised his price target for the shares for $131 from $81. Higher competing protein prices and improving U.S. export prospects "make a more negative stance unsustainable," Samuelson contends. He raised his fiscal 2020 and 2021 margin forecasts for the company to "normalized levels." However, further upside is tempered, for now, by increases in U.S. processing capacity coming on stream over the next 18 months, the analyst contends.
03/13/19
03/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Carnival (CCL) upgraded to Buy from Neutral at Goldman Sachs analyst Stephen Grambling citing the company accelerating its net unit growth from 2.5% in the last 3 years to 5% over the next 3 years and also believes that concerns about net yields in Europe are overblown. 2. Sanderson Farms (SAFM) upgraded to Neutral from Underweight at JPMorgan with analyst Ken Goldman saying he now views the stock's upside/downside risk as balanced. 3. Axis Capital (AXS) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Meyer Shields saying Axis is positioned for strong underwriting improvement. 4. Broadridge (BR) upgraded to Outperform from Market Perform at Raymond James with analyst Patrick O'Shaughnessy saying he believes Broadridge's current valuation offers investors an attractive entry point into a differentiated, high barrier to entry business. 5. Aurora Cannabis (ACB) upgraded to Buy from Hold at GMP Securities with analyst Martin Landry saying new high profile strategic advisor Nelson Peltz could be "instrumental" in facilitating partnership talks with large consumer packaged goods companies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VC Visteon
$80.45

-0.37 (-0.46%)

01/28/19
BMOC
01/28/19
NO CHANGE
BMOC
BorgWarner, Gentherm, Visteon, Autolive price targets raised at BMO Capital
BMO Capital analyst Richard Carlso is turning more bullish on the auto and mobility equipment industry, saying the sentiment from the most recent CES, Detroit Auto Show, and GM's (GM) Capital Markets Day events has shifted his outlook from "cautious" to "cautiously optimistic". The analyst attributes the snap-back rally in the sector stocks' prices to increased optimism over the impact of lingering trade issues and outlooks from companies that have so far updated on their Q4 performance, all of which suggested that the 2018-end declines were overextended. Carlson is raising his price target on Autoliv (ALV) to $84 from $79, on Gentex (GNTX) to $27 from $24, on Aptiv (APTV) to $84 from $74, on Veoneer (VNE) to $41 from $36, on BorgWarner (BWA) to $49 from $44, and on Visteon (VC) to $91 from $84.
04/23/19
BARD
04/23/19
UPGRADE
BARD
Outperform
Visteon upgraded to Outperform from Neutral at Baird
04/23/19
BARD
04/23/19
UPGRADE
BARD
Baird says autos attractive, upgrades Veoneer to Neutral, Visteon to Outperform
As previously reported, Baird analyst David Leiker upgraded Visteon (VC) to Outperform from Neutral and upgraded Veoneer (VNE) to Neutral from Underperform, citing his broader industry view that the recent rally in auto supplier stocks "has legs" and can be sustained into 2020 given the stabilizing end market backdrop, ongoing content growth and low valuations. While Visteon still faces "severe" near-term challenges, the company's updated backlog communication reinforces what should be the sector's fastest organic revenue growth across 2020-21, said Leiker, who raised his price target on the shares to $108 from $87. For Veoneer, he now views the risk/reward as balanced and raised his price target on those shares to $28 from $21.
02/25/19
BMOC
02/25/19
NO CHANGE
Target $103
BMOC
Outperform
Visteon price target raised to $103 from $91 at BMO Capital
BMO Capital analyst Richard Carlson raised his price target on Visteon to $103 and kept his Outperform rating after its Q4 earnings and continued order growth coming at an "impressive rate". The analyst notes that in spite of the 50% year-to-date bounce in the stock price, Visteon shares are still trading well below the 52-week highs, adding that his new price target also assumes a bump in valuation as investors shift to a multi-year growth outlook.
VNE Veoneer
$28.16

-1.04 (-3.56%)

04/23/19
BARD
04/23/19
UPGRADE
BARD
Neutral
Veoneer upgraded to Neutral from Underperform at Baird
02/14/19
NORD
02/14/19
DOWNGRADE
NORD
Hold
Veoneer downgraded to Hold from Buy at Nordea
SNE Sony
$47.95

0.34 (0.71%)

04/23/19
MACQ
04/23/19
UPGRADE
MACQ
Outperform
Sony upgraded to Outperform from Neutral at Macquarie
04/15/19
JEFF
04/15/19
UPGRADE
Target $58
JEFF
Buy
Jefferies takes Sony back to Buy with $58 target amid activist pressure
Jefferies analyst Atul Goyal upgraded Sony to Buy from Hold and raised his price target for the shares to $58 from $50.70. The analyst just a few weeks ago on March 20 downgraded the shares to Hold from Buy. Pressure is mounting on Sony to exit its loss-making Smartphone business, Goyal tells investors in a research note. After removing the business from his sum-of-the-parts analysis, the analyst sees 20% upside in the stock. Further, Goyal thinks downside in Sony shares is limited with the presence of activists. The stock in early trading is up 18c to $47.17.
04/15/19
04/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Neutral from Sell at BTIG with analyst Richard Greenfield saying the rating change was prompted more by the commentary from CEO Bob Iger on CNBC than by the company's investor day presentation unveiling Disney+. 2. Western Digital (WDC) upgraded to Buy from Neutral at Longbow with analyst Nikolay Todorov saying NAND fundamentals are bottoming and "there is a line of sight to cyclical recovery." 3. Dow Inc. (DOW), Huntsman (HUN), LyondellBasell (LYB), and Eastman Chemical (EMN) upgraded to Buy from Neutral at Nomura Instinet, while Olin (OLN) and Westlake Chemical (WLK) were upgraded to Neutral from Reduce. 4. Waste Management (WM) upgraded to Buy from Hold at Stifel with analyst Michael Hoffman saying even with potential divestitures to get the deal approved, adding Advanced Disposal "dramatically lowers" Waste Management's cost of capital, reduces capital spending, converts more of the fleet to CNG, and stimulates tuck-in activity that should all drive sustainable free cash flow growth. 5. Sony (SNE) upgraded to Buy from Hold at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/16/19
BARD
04/16/19
NO CHANGE
BARD
Sony 'PS5' details largely in line with expectations, says Baird
After Sony (SNE) shared details around its upcoming next-generation game console, widely referred to as the "PlayStation 5," Baird analyst Colin Sebastian said the details - including plans for significant GPU and CPU upgrades and the inclusion of a solid state hard drive - are largely in line with his expectations and support his view that the next generation of consoles should be "a major catalyst" for software sales in 2020-2021 and beyond. Sony's announcement that the next-gen console will include a physical disc drive is a potential positive for GameStop's (GME) used and pre-owned console software segments, added Sebastian. Video game software makers include Electronic Arts (EA), Take-Two (TTWO) and Activision Blizzard (ATVI).

TODAY'S FREE FLY STORIES

AAPL

Apple

$211.42

4.98 (2.41%)

12:51
08/19/19
08/19
12:51
08/19/19
12:51
Periodicals
Apple Arcade to likely be priced at $4.99/month, 9to5Mac reports »

Apple Arcade,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.67

-0.01 (-0.27%)

12:48
08/19/19
08/19
12:48
08/19/19
12:48
Hot Stocks
Fortuna Silver reports fatal accident at San Jose mine »

Fortuna Silver Mines said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVRA

Savara

$2.23

0.03 (1.36%)

12:40
08/19/19
08/19
12:40
08/19/19
12:40
Conference/Events
Savara management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

G

Genpact

$41.30

0.51 (1.25%)

, FB

Facebook

$186.67

3.25 (1.77%)

12:40
08/19/19
08/19
12:40
08/19/19
12:40
Periodicals
Facebook contractor raises wages for Indian content reviewers, Reuters reports »

Genpact (G), a Facebook…

G

Genpact

$41.30

0.51 (1.25%)

FB

Facebook

$186.67

3.25 (1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

KAR

KAR Auction

$25.67

0.18 (0.71%)

12:39
08/19/19
08/19
12:39
08/19/19
12:39
Conference/Events
KAR Auction management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 23

    Sep

  • 13

    Nov

ZS

Zscaler

$74.34

-6.5 (-8.04%)

12:37
08/19/19
08/19
12:37
08/19/19
12:37
Recommendations
Zscaler analyst commentary  »

Zscaler slides after OTR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 10

    Oct

  • 15

    Oct

ENVA

Enova International

$24.92

0.31 (1.26%)

12:37
08/19/19
08/19
12:37
08/19/19
12:37
Conference/Events
Enova International management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 20

    Sep

  • 13

    Nov

AZN

AstraZeneca

$44.38

0.02 (0.05%)

12:33
08/19/19
08/19
12:33
08/19/19
12:33
Conference/Events
AstraZeneca management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 09

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

PCG

PG&E

$10.35

-3.95 (-27.62%)

, AMGN

Amgen

$202.49

-1.46 (-0.72%)

12:22
08/19/19
08/19
12:22
08/19/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been rising…

PCG

PG&E

$10.35

-3.95 (-27.62%)

AMGN

Amgen

$202.49

-1.46 (-0.72%)

PANW

Palo Alto Networks

$196.50

-2.76 (-1.39%)

WB

Weibo

$41.70

4.65 (12.55%)

DRYS

DryShips

$5.19

1.355 (35.38%)

EL

Estee Lauder

$197.80

18.54 (10.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 04

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

LOW

Lowe's

$95.37

1.46 (1.55%)

, HD

Home Depot

$206.92

3.28 (1.61%)

12:19
08/19/19
08/19
12:19
08/19/19
12:19
On The Fly
Fly Intel: What to watch in Home Depot, Lowe's earnings reports »

Home improvement…

LOW

Lowe's

$95.37

1.46 (1.55%)

HD

Home Depot

$206.92

3.28 (1.61%)

JCP

J.C. Penney

$0.61

0.0122 (2.04%)

SHLD

Sears

$0.00

(0.00%)

AMZN

Amazon.com

$1,823.13

31.31 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 23

    Sep

  • 25

    Sep

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/19/19
08/19
12:17
08/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,202.00

25.06 (2.13%)

, GOOGL

Alphabet Class A

$1,204.36

25.67 (2.18%)

12:16
08/19/19
08/19
12:16
08/19/19
12:16
Hot Stocks
Trump says 'Google should be sued' over role in 2016 election »

President Donald Trump…

GOOG

Alphabet

$1,202.00

25.06 (2.13%)

GOOGL

Alphabet Class A

$1,204.36

25.67 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/19/19
08/19
12:16
08/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APAM

Artisan Partners

$26.64

0.43 (1.64%)

12:14
08/19/19
08/19
12:14
08/19/19
12:14
Conference/Events
Artisan Partners management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

ARMK

Aramark

$40.72

3.65 (9.85%)

, PCG

PG&E

$10.43

-3.87 (-27.06%)

12:13
08/19/19
08/19
12:13
08/19/19
12:13
On The Fly
Aramark upgrades, PG&E double downgrade among today's top analyst calls »

Check out today's top…

ARMK

Aramark

$40.72

3.65 (9.85%)

PCG

PG&E

$10.43

-3.87 (-27.06%)

CVX

Chevron

$117.16

1.37 (1.18%)

XOM

Exxon Mobil

$69.22

0.92 (1.35%)

BTU

Peabody Energy

$19.31

0.13 (0.68%)

ARLP

Alliance Resource Partners

$14.95

(0.00%)

SONO

Sonos

$13.14

1.24 (10.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

QUOT

Quotient Technology

$7.84

0.035 (0.45%)

12:11
08/19/19
08/19
12:11
08/19/19
12:11
Hot Stocks
Elk Creek Partners reports 5.37% passive stake in Quotient Technology »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 12

    Sep

12:05
08/19/19
08/19
12:05
08/19/19
12:05
General news
Treasury's $87 B 3- and 6-month bill auctions were mixed »

Treasury's $87 B 3-…

BMA

Banco Macro

$34.53

-3.75 (-9.80%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Banco Macro falls -9.8% »

Banco Macro is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBAR

BBVA

$5.29

-0.575 (-9.80%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
BBVA falls -10.0% »

BBVA is down -10.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$10.29

-4.01 (-28.04%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
PG&E falls -27.9% »

PG&E is down -27.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$197.12

17.86 (9.96%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Estee Lauder rises 9.9% »

Estee Lauder is up 9.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

MYOV

Myovant Sciences

$7.90

0.92 (13.18%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Myovant Sciences rises 13.1% »

Myovant Sciences is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NM

Navios Maritime

$4.98

0.58 (13.18%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Navios Maritime rises 13.3% »

Navios Maritime is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPYY

Repsol

$0.00

(0.00%)

11:56
08/19/19
08/19
11:56
08/19/19
11:56
Downgrade
Repsol rating change at Barclays »

Repsol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLM

Martin Marietta

$254.47

-0.27 (-0.11%)

11:56
08/19/19
08/19
11:56
08/19/19
11:56
Conference/Events
Martin Marietta management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.